Trump signs order to expedite psychedelic drug treatment access
An executive order has been signed to facilitate the review of psychedelic drugs for therapeutic use. This includes substances like ibogaine, which has gained attention among certain groups. (sources: nbcnews, usatoday, cbsnews, pbs, cnn)
The executive order aims to accelerate the research and approval process for psychedelic treatments. This move follows discussions around the potential benefits of these substances for various health issues.
- The executive order focuses on speeding up reviews of psychedelic drugs, including ibogaine.
- The order has garnered interest from combat veterans and some lawmakers.
- The initiative follows a public conversation involving media personality Joe Rogan.
Why it matters
The order could influence the availability of alternative treatments for mental health conditions.
↓ Why this is on ModernAction
This story is connected to Freedom to Heal Act of 2025 — legislation your representatives will vote on.
S3346 · 119th Congress
Freedom to Heal Act of 2025
Where do you stand on this bill?
Takes about 60 seconds
About this bill
What S3346 actually does
This story is about Trump signs order to accelerate access to psychedelic drug treatments. This bill would require DOJ to create a special registration for physicians to administer Schedule I eligible investigational drugs under.
If passed, it would:
- Require DOJ to create a special registration for physicians to administer Schedule I eligible investigational drugs • Impose timing/safeguard requirements for approving (or challenging) registrations.
Top coverage · 9 sources